Onconetix Inc (ONCO)
1.64
-0.08
(-4.65%)
USD |
NASDAQ |
Nov 14, 16:00
1.74
+0.10
(+6.10%)
After-Hours: 20:00
Onconetix Enterprise Value: 22.53M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 22.53M |
| November 12, 2024 | 22.56M |
| November 11, 2024 | 22.72M |
| November 08, 2024 | 23.07M |
| November 07, 2024 | 23.06M |
| November 06, 2024 | 23.06M |
| November 05, 2024 | 23.36M |
| November 04, 2024 | 23.41M |
| November 01, 2024 | 23.41M |
| October 31, 2024 | 23.40M |
| October 30, 2024 | 23.45M |
| October 29, 2024 | 23.51M |
| October 28, 2024 | 23.92M |
| October 25, 2024 | 24.10M |
| October 24, 2024 | 24.24M |
| October 23, 2024 | 25.02M |
| October 22, 2024 | 25.14M |
| October 21, 2024 | 25.40M |
| October 18, 2024 | 25.61M |
| October 17, 2024 | 25.45M |
| October 16, 2024 | 25.26M |
| October 15, 2024 | 25.48M |
| October 14, 2024 | 25.87M |
| October 11, 2024 | 25.67M |
| October 10, 2024 | 25.09M |
| Date | Value |
|---|---|
| October 09, 2024 | 24.97M |
| October 08, 2024 | 25.05M |
| October 07, 2024 | 24.94M |
| October 04, 2024 | 24.75M |
| October 03, 2024 | 24.60M |
| October 02, 2024 | 24.68M |
| October 01, 2024 | 24.51M |
| September 30, 2024 | 25.12M |
| September 27, 2024 | 25.69M |
| September 26, 2024 | 23.75M |
| September 25, 2024 | 23.76M |
| September 24, 2024 | 24.13M |
| September 23, 2024 | 23.46M |
| September 20, 2024 | 23.70M |
| September 19, 2024 | 24.69M |
| September 18, 2024 | 24.77M |
| September 17, 2024 | 25.01M |
| September 16, 2024 | 24.86M |
| September 13, 2024 | 24.90M |
| September 12, 2024 | 25.20M |
| September 11, 2024 | 25.00M |
| September 10, 2024 | 24.87M |
| September 09, 2024 | 25.11M |
| September 06, 2024 | 24.99M |
| September 05, 2024 | 25.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-14.90M
Minimum
Nov 09 2022
748.23M
Maximum
Mar 15 2022
40.19M
Average
15.92M
Median
Mar 21 2024
Enterprise Value Benchmarks
| CEL-SCI Corp | 38.36M |
| AIM ImmunoTech Inc | 7.900M |
| IGC Pharma Inc | 26.09M |
| NovaBay Pharmaceuticals Inc | 2.762M |
| Protalix BioTherapeutics Inc | 66.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.31M |
| Revenue (Quarterly) | 0.7048M |
| Total Expenses (Quarterly) | 2.822M |
| EPS Diluted (Quarterly) | -25.60 |
| Gross Profit Margin (Quarterly) | 14.29% |
| Profit Margin (Quarterly) | -2.03K% |
| Earnings Yield | -6.63K% |